NAV Growth

Growth of each fund's NAV over the selected period, rebased to 0%

Growth of each fund's NAV over the selected period, rebased to 0%

‌

Fund Details

Fund Details	Invesco India Pharma and Healthcare Fund - Direct (G)
Fund Type	Equity
Risk	Very High
Min SIP Amount	₹100
Min Lumpsum	₹1,000
Expense Ratio	3.30%
NAV	₹10.53 (11 Nov 2026)
Fund Size	₹475.83 Cr
Fund Started	07 Sept 2026
Lock-in Period	No lock-in
Exit Load	If units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% If units are redeemed/switched-out after 3 months: Nil Switch between the Plans under the Scheme: Nil.

Returns	Invesco India Pharma and Healthcare Fund - Direct (G)
1M	11.73%
3M	—
6M	—
1Y	—
3Y	—
5Y	—
Since Inception	4.80%

Trailing risk-adjusted performance measures

Risk Ratio	Invesco India Pharma and Healthcare Fund - Direct (G)
Alpha	-4.29
Beta	0.27
Sharpe	0.00
Standard Deviation	0.00

Holding Analysis	Invesco India Pharma and Healthcare Fund - Direct (G)
Top 5 Holdings	43.21%
Top 10 Holdings	78.14%
Portfolio Turnover	—
Equity	97.04%
Debt	3.16%
Cash	—

Name	Assets
Apollo Hospitals En...Equity	9.08%
Divis Laboratories LtdEquity	8.74%
Max Healthcare Inst...Equity	8.59%
Sai Life Sciences LtdEquity	8.49%
Sun Pharmaceutical ...Equity	8.31%
Manipal Health Ente...Equity	7.97%
Dr Agarwals Health ...Equity	7.93%
Sahajanand Medical ...Equity	7.31%
Global Health LtdEquity	5.96%
Corona Remedies LtdEquity	5.76%

Fund Manager	Invesco India Pharma and Healthcare Fund - Direct (G)
Name
Managing Since	18 Aug 2026

About	Invesco India Pharma and Healthcare Fund - Direct (G)
AMC	Invesco Mutual Fund
Scheme Category	Sectoral Fund
Benchmark	BSE Healthcare TRI
Launch Date	18 Aug 2026